Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether an angiotensin II receptor blocker
(olmesartan), in addition to conventional treatment, will reduce the mortality and morbidity
in hypertensive patients with stable chronic heart failure.